-
Posted by
Two Blokes Jul 29 -
Filed in
Stock
-
10 views
Transformative acquisition projected to generate up to an additional $7 million in annualized revenue in 2025 and further expand bottom line. Brings HACCP, GMP-certified, and FDA-registered manufacturing in-house for the first time, with production capacity scalable to $20 million in annual revenue and potential to reach full capacity in 2026.
